CHF 718

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF 718, covering 2021-12-14 to 2021-12-14. Get the full timeline:

Most recent: Clinical Trial Update: An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects [Phase 2]